France · Delayed Price · Currency is EUR Cellectis Statistics
Total Valuation
Cellectis has a market cap or net worth of EUR 208.64 million. The enterprise value is 133.07 million.
| Market Cap | 208.64M |
| Enterprise Value | 133.07M |
Important Dates
The last earnings date was Thursday, August 6, 2026.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Cellectis has 72.70 million shares outstanding. The number of shares has increased by 0.22% in one year.
| Current Share Class | 72.70M |
| Shares Outstanding | 72.70M |
| Shares Change (YoY) | +0.22% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 2.19% |
| Owned by Institutions (%) | 15.89% |
| Float | 46.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.73 |
| PB Ratio | 5.80 |
| P/TBV Ratio | 5.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.38 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.37, with a Debt / Equity ratio of 1.96.
| Current Ratio | 1.37 |
| Quick Ratio | 1.34 |
| Debt / Equity | 1.96 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.83 |
| Interest Coverage | -7.18 |
Financial Efficiency
Return on equity (ROE) is -94.54% and return on invested capital (ROIC) is -23.43%.
| Return on Equity (ROE) | -94.54% |
| Return on Assets (ROA) | -11.67% |
| Return on Invested Capital (ROIC) | -23.43% |
| Return on Capital Employed (ROCE) | -43.80% |
| Weighted Average Cost of Capital (WACC) | 16.50% |
| Revenue Per Employee | 246,098 |
| Profits Per Employee | -251,847 |
| Employee Count | 229 |
| Asset Turnover | 0.21 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -307,230 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.33% in the last 52 weeks. The beta is 2.75, so Cellectis's price volatility has been higher than the market average.
| Beta (5Y) | 2.75 |
| 52-Week Price Change | +12.33% |
| 50-Day Moving Average | 2.58 |
| 200-Day Moving Average | 3.23 |
| Relative Strength Index (RSI) | 62.15 |
| Average Volume (20 Days) | 116,493 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cellectis had revenue of EUR 55.86 million and -57.17 million in losses. Loss per share was -0.57.
| Revenue | 55.86M |
| Gross Profit | 55.86M |
| Operating Income | -50.77M |
| Pretax Income | -57.48M |
| Net Income | -57.17M |
| EBITDA | -40.86M |
| EBIT | -50.77M |
| Loss Per Share | -0.57 |
Balance Sheet
The company has 145.90 million in cash and 70.33 million in debt, with a net cash position of 75.57 million or 1.04 per share.
| Cash & Cash Equivalents | 145.90M |
| Total Debt | 70.33M |
| Net Cash | 75.57M |
| Net Cash Per Share | 1.04 |
| Equity (Book Value) | 35.95M |
| Book Value Per Share | 0.49 |
| Working Capital | 43.29M |
Cash Flow
In the last 12 months, operating cash flow was -36.43 million and capital expenditures -1.91 million, giving a free cash flow of -38.34 million.
| Operating Cash Flow | -36.43M |
| Capital Expenditures | -1.91M |
| Depreciation & Amortization | 9.69M |
| Net Borrowing | -14.00M |
| Free Cash Flow | -38.34M |
| FCF Per Share | -0.53 |
Margins
Gross margin is 100.00%, with operating and profit margins of -90.87% and -102.34%.
| Gross Margin | 100.00% |
| Operating Margin | -90.87% |
| Pretax Margin | -102.89% |
| Profit Margin | -102.34% |
| EBITDA Margin | -73.14% |
| EBIT Margin | -90.87% |
| FCF Margin | n/a |
Dividends & Yields
Cellectis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.22% |
| Shareholder Yield | -0.22% |
| Earnings Yield | -27.40% |
| FCF Yield | -18.38% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cellectis has an Altman Z-Score of -1.16 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.16 |
| Piotroski F-Score | 2 |